Navigation Links
Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Date:5/13/2008

COGNIS(TM) CRT-D and TELIGEN(TM) ICD represent entirely new platforms

NATICK, Mass., May 13 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval of its COGNIS(TM) cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN(TM) implantable cardioverter defibrillator (ICD). These devices represent entirely new platforms to treat heart failure and sudden cardiac death and are the result of a multi-year research and development effort to provide physicians enhanced clinical options for their patients.

"COGNIS and TELIGEN are truly breakthrough technologies featuring significant engineering advances," said Jim Tobin, President and Chief Executive Officer of Boston Scientific. "These products are testaments to the revitalization of our CRM business and our strong product pipeline. With more than 10 worldwide regulatory approvals since the beginning of the year and several others planned, we are delivering enhanced therapy systems designed to meet clinician needs for safety, reliability and better patient outcomes."

"When prescribing a high-energy device, I often had to make trade-offs among device size, battery longevity and features," said Poul-Erik Bloch-Thomson, M.D., KAS Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. "The COGNIS and TELIGEN devices eliminate those trade-offs without compromising therapy options."

The COGNIS CRT-D and the TELIGEN ICD are among the world's smallest and thinnest high-energy devices at 32.5 cc and 31.5 cc respectively, while less than 10 mm thick. Both devices offer features based on substantial engineering advances, including extended battery longevity over previous Company devices
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. TrimWater Keeps Boston Beautiful
2. Highlights for APAs 116th Annual Convention in Boston, Aug. 14-17
3. Boston Scientific Announces FDA Approval of New Family of Advanced Pacemakers
4. Boston Medical Center/Boston University School of Medicine researcher receives award
5. VA Retains Facilities at Four Boston Campuses
6. Boston Scientific to Participate in Deutsche Bank Conference
7. CVS Caremark and JVS Announce Grand Opening of the Boston Regional Learning Center
8. Boston Scientific to Participate in Morgan Stanley Conference
9. Boston Scientific Completes Enrollment in Landmark Heart Failure Trial
10. Boston Scientific Named Healthcare Supplier of the Year by Global Healthcare Exchange (GHX)
11. Philips Supports the Boston Marathon as the Sole Provider of Life-Saving Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...Newswire/ -- The Children,s,Hospital of Philadelph...,gift that will enable the opening of a new pediat...gift, made possible by Athena and Nicholas,Karabot... the history of,Children,s Hospital and will give ...munities convenient access to world-class pediatri...
(Date:7/23/2008)... -- The American Heart,Association announces the c...t Award, the association,s highest honor for healt...ed in 2000, to recognize and honor the career,achi...s who have documented,the considerable progress ma...This career achievement award was created in memor...
(Date:7/23/2008)...mes may be tough, but,Hollywood,s young stars like...azzling new smile to boost confidence. Cosmetic de...clients beam in on success, citing his,experience ...fidence they,need for stardom. In agreement is Lan...smile designed by Dr. Kosdon., MTV,s Rock The Cra...
(Date:7/23/2008)...Newswire/ -- The Alameda County,Place Matters Team...akland,Marriott to address the social conditions t...om low-income and communities of color. Over 100,r...ll attend. Place Matters,is a national initiative ...dies, Health Policy Institute and is funded by the...
Breaking Medicine News(10 mins):Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 2Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 3Health News:Rock The Cradle's Bad Boy Landon Brown Owes His Irresistible New Smile to Dr. Michael Kosdon 2Health News:Alameda County Hosts National Initiative to Reduce Health Disparities 2
... come up with a bill seeking direct control over a... centres in the state, State Health Minister Digam...roduce a special bill in the next assembly session...perating in the state. This is to check activities...
...that folic acid supplements can help to prevent ca...//. Published in the July 15, 2006 issue of CANC...oom), a peer-reviewed journal of the American Canc...1 of 43 patients with the precancerous laryngeal l...
...rogrammer flew in to Boston from India, on April 2...ervices company headquartered //in the 18th floor ...ze that a potential measles outbreak loomed before...toms of measles such as rash, fever, cough began t...
...t a new report looked at new prescription- only m...d 2006 //. In the last six years, 78 new prescri...alian PBS, which was the equivalent of Pharmac. O...stered in New Zealand, of which only 20 are funde...
Other Medicine News:Health News:Folic Acid Supplements to Prevent Cancer 2Health News:Global Threat of Measles Outbreak 2
(Date:7/22/2008)...Meeting to Discuss Development Plan Completed Succ...rstCall/ -- Amarin Corporation,plc (NASDAQ: AMRN ...th,officials at the U.S. Food and Drug Administrat...p AMR101 for the treatment of,hypertriglyceridemia...eeding to Phase 3 with AMR101 in hypertriglyceride...
(Date:7/22/2008)...mens Including Lantus(R) and Apidra(R) Resulted in...ype 2 Diabetes, Whatever the Algorithm ...ly 22 /- Results from the "Adjust to,...Algorithm to Carbohydrate,Counting for Adjustment ...ed in the American Diabetes Association,s (ADA) me...
(Date:7/22/2008)...mic treatment with chemotherapy and pegylated enzy...pared to chemotherapy alone - - P... 22 /- Halozyme Therapeutic...any developing and,commercializing products target...presentation of positive pre-clinical animal effic...
(Date:7/22/2008)...ANTIPOLIS, France, July 22 /PRNewswire-FirstCall/ ...d it has successfully completed the,enrollment of ...ypertension,in two clinical pharmacology studies i...nced timelines. These trials are designed to asses...mparison to ibuprofen and,naproxen, using the Ambu...
Breaking Medicine Technology:Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Drinking away anxiety a new program finds safer ways for college students to cope 6889 1Drinking away anxiety a new program finds safer ways for college students to cope 6889 2Planting carbon deep in the earth rather than the greenhouse 1327 1Planting carbon deep in the earth rather than the greenhouse 1327 2Omega 3 fatty acids protect against Parkinsons study says 1325 1Omega 3 fatty acids protect against Parkinsons study says 1325 2Environmental researchers propose radical human centric map of the world 1323 1Environmental researchers propose radical human centric map of the world 1323 2
...FLEMINGTON, N.J.--(BUSINESS WIRE)--Jun 5, 2007 - N...ceutical company developing,oral spray formulation...announced that its two clinical studies comparing ... their primary,pharmacokinetic (PK), pharmacodynam...e currently marketed as Ambien(R), a leading,drug ...
... -- EORTC 18991 Phase III Study Results Presented ...Long-term treatment with,pegylated interferon alfa...stained impact on relapse-free survival (RFS),acc...l ever,conducted in patients with stage III melano...opean Organisation for the Research and,Treatment ...
Other Medicine Technology:NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 2NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 3NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 5NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 6NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 7Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 2Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 3Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 4Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 5
Protects the eye from symptoms caused by "dry eye, medical conditions, drug reactions and environmental factors. Forms a moisture chamber over the eye area during rest.
...tronic Ophthalmics offers the most comprehensive f... Instruments for Cataract incision, Glaucoma filtr...te coagulation is achieved with minimal tissue tra...ight eraser styles are available in 18, 20, and 20...
...tronic Ophthalmics offers the most comprehensive f... Instruments for Cataract incision, Glaucoma filtr...te coagulation is achieved with minimal tissue tra...ight eraser styles are available in 18, 20, and 20...
...tronic Ophthalmics offers the most comprehensive f... Instruments for Cataract incision, Glaucoma filtr...te coagulation is achieved with minimal tissue tra...ight eraser styles are available in 18, 20, and 20...
Medicine Products: